[1] Bi YH, Chen QJ, Wang QL, Chen JJ, Jin T, Wong G, et al. Genesis, evolution and prevalence of H5N6 avian influenza viruses in China. Cell Host Microbe 2016;20(6):810 − 21. http://dx.doi.org/10.1016/j.chom.2016.10.022CrossRef
[2] World Health Organization. Avian influenza weekly update number 814. https://www.who.int/docs/default-source/wpro---documents/emergency/surveillance/avian-influenza/ai_20211015.pdf?Status=Master&sfvrsn=5f006f99_57. [2021-10-19].https://www.who.int/docs/default-source/wpro---documents/emergency/surveillance/avian-influenza/ai_20211015.pdf?Status=Master&sfvrsn=5f006f99_57
[3] World Health Organization. Avian influenza weekly update number 759. https://iris.wpro.who.int/bitstream/handle/10665.1/14460/AI-20200918.pdf. [2021-9-20].https://iris.wpro.who.int/bitstream/handle/10665.1/14460/AI-20200918.pdf
[4] Pan M, Gao RB, Lv Q, Huang SH, Zhou ZH, Yang L, et al. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings. J Infect 2016;72(1):52 − 9. http://dx.doi.org/10.1016/j.jinf.2015.06.009CrossRef
[5] Faust JS, Del Rio C. Assessment of deaths from COVID-19 and from seasonal influenza. JAMA Intern Med 2020;180(8):1045 − 6. http://dx.doi.org/10.1001/jamainternmed.2020.2306CrossRef
[6] World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2021, 15 April 2021. 2021. https://www.who.int/publications/m/item/cumulative-number-of-confirmed-human-cases-for-avian-influenza-a(h5n1)-reported-to-who-2003-2021-15-april-2021. [2021-9-29].https://www.who.int/publications/m/item/cumulative-number-of-confirmed-human-cases-for-avian-influenza-a(h5n1)-reported-to-who-2003-2021-15-april-2021
[7] Xiao CK, Xu JA, Lan Y, Huang ZP, Zhou LJ, Guo YX, et al. Five independent cases of human infection with avian influenza H5N6 — Sichuan Province, China, 2021. China CDC Wkly 2021;3(36):751 − 6. http://dx.doi.org/10.46234/ccdcw2021.187CrossRef
[8] Feng LZ, Zhang T, Wang Q, Xie YR, Peng ZB, Zheng JD, et al. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nat Commun 2021;12(1):3249. http://dx.doi.org/10.1038/s41467-021-23440-1CrossRef
[9] Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun 2021;12(1):1001. http://dx.doi.org/10.1038/s41467-021-21157-9CrossRef
[10] Zhang Y, Chen MM, Huang YW, Zhu WF, Yang L, Gao LD, et al. Human infections with novel reassortant H5N6 avian influenza viruses in China. Emerg Microbes Infect 2017;6(1):1 − 2. http://dx.doi.org/10.1038/emi.2017.38CrossRef
[11] Chen P, Xie JF, Lin Q, Zhao L, Zhang YH, Chen HB, et al. A study of the relationship between human infection with avian influenza a (H5N6) and environmental avian influenza viruses in Fujian, China. BMC Infect Dis 2019;19(1):762. http://dx.doi.org/10.1186/s12879-019-4145-6CrossRef
[12] Su K, Ye S, Li Q, Xie WJ, Yu HY, Qi L, et al. Influenza A(H7N9) virus emerged and resulted in human infections in Chongqing, southwestern China since 2017. Int J Infect Dis 2019;81:244 − 50. http://dx.doi.org/10.1016/j.ijid.2019.02.011CrossRef
[13] Cowling BJ, Jin LM, Lau EH, Liao QH, Wu P, Jiang H, et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet 2013;382(9887):129 − 37. http://dx.doi.org/10.1016/S0140-6736(13)61171-XCrossRef
[14] Jiang H, Wu P, Uyeki TM, He JF, Deng ZH, Xu W, et al. Preliminary epidemiologic assessment of human infections with highly pathogenic avian influenza A(H5N6) virus, China. Clin Infect Dis 2017;65(3):383 − 8. http://dx.doi.org/10.1093/cid/cix334CrossRef
[15] Wang D, Yang L, Gao R, Zhang X, Tan Y, Wu A, et al. Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013. Euro Surveill 2014;19(25):20836. http://dx.doi.org/10.2807/1560-7917.es2014.19.25.20836CrossRef
[16] Su S, Bi YH, Wong G, Gray GC, Gao GF, Li SJ. Epidemiology, evolution, and recent outbreaks of avian influenza virus in China. J Virol 2015;89(17):8671 − 6. http://dx.doi.org/10.1128/JVI.01034-15CrossRef
[17] Du YY, Chen MY, Yang JY, Jia YE, Han SF, Holmes EC, et al. Molecular evolution and emergence of H5N6 avian influenza virus in central China. J Virol 2017;91(12):e00143 − 17. http://dx.doi.org/10.1128/JVI.00143-17CrossRef
[18] Gao SM, Kang YF, Li SY, Xiang B, Ma HL, Yuan RY. Increasing genetic diversity of H5N6 avian influenza virus in China: a serious threat to persistence and dissemination in Guangdong province. J Infect 2017;75(6):586 − 90. http://dx.doi.org/10.1016/j.jinf.2017.10.003CrossRef
[19] Gao GF. Influenza and the live poultry trade. Science 2014;344(6181):235. http://dx.doi.org/10.1126/science.1254664CrossRef
[20] Bi YH, Mei K, Shi WF, Liu D, Yu XL, Gao ZM, et al. Two novel reassortants of avian influenza A (H5N6) virus in China. J Gen Virol 2015;96(5):975 − 81. http://dx.doi.org/10.1099/vir.0.000056CrossRef